Target intelligence / Profile preview

Plexin-A receptor (Plexin-A)

Target
Plexin-A
Molecular classification
Receptor, Transmembrane receptor, GTPase-activating protein (GAP)-domain protein, Semaphorin receptor
01

Overview

Plexin-A receptors are a family of large transmembrane cell surface receptors that serve as the main signaling receptors for the semaphorin family of proteins. The family consists of four members in humans: Plexin-A1, Plexin-A2, Plexin-A3, and Plexin-A4. These receptors possess an extracellular Sema domain (for ligand binding) followed by alternating PSI and IPT domains, and a highly conserved intracellular region with a split GTPase-activating protein (GAP) domain separated by a Rho-GTPase binding domain (RBD). Upon binding semaphorin ligands, often with the involvement of neuropilin co-receptors, they transduce signals critical for neuronal axon guidance, immune cell regulation, angiogenesis, and cell migration. Their signaling involves changes in small GTPase activity and is tightly controlled through autoinhibition and activation mechanisms. Plexin-A signaling is implicated in cancer progression, nervous system development, inflammation, and vascular biology. No approved clinical drugs directly target Plexin-A receptors, and therapeutic modulation poses risks due to their broad roles in development and tissue homeostasis.

Other names
Plexin Class APlexin-A1Plexin-A2Plexin-A3Plexin-A4semaphorin receptor
02

Mechanism of action

Modulation of semaphorin-plexin signaling (ligand binding triggers conformational changes and signal transduction). Regulation of intracellular GTPase signaling via GAP domain, affecting small GTPases (e.g., Ras, Rho, Rap). Downstream modulation of cytoskeletal and adhesive machinery, impacting cell migration, axon guidance, and immune response.

03

Biological functions

Signal transductionRegulation of neuronal axon guidanceRegulation of cell migrationModulation of cytoskeletal dynamicsImmune responseAngiogenesisPromotion of Hedgehog signaling
04

Disease associations

Cancer (particularly in tumor progression and metastasis)Neurodegenerative disease (impaired axon guidance, neuronal repair)Inflammatory disordersCardiovascular disease (angiogenesis-related roles)Other (including developmental disorders)
05

Safety considerations

Targeting Plexin-A receptors could affect neural development and repair, increasing risk of neurodevelopmental or neuropsychiatric side effectsPotential impact on immune function and vascular health due to angiogenesis and immune cell migration rolesModulation could disrupt normal cell migration and tissue remodeling
06

Interacting drugs

No approved or widely recognized drugs directly targeting Plexin-A receptors as of 2025. Research compounds, such as semaphorin inhibitors or mimetics, are studied experimentally

1 more in the full profile.

07

Biomarkers

Expression levels of Plexin-A family members (PLXNA1–4) are studied as biomarkers in certain cancers and neurological conditions, but no widely used clinical biomarker exists to dateExperimental: association of plexin expression with axon guidance and tumor tissue prognosis

Beyond the preview

Go deeper on Plexin-A receptor (Plexin-A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plexin-A receptor (Plexin-A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call